Meeting
2022 ASCO Annual Meeting
KRAS wild-type pancreatic ductal adenocarcinoma: Molecular and therapeutic opportunities.
Authors
Aakash Desai
Mayo Clinic Rochester, Rochester, MN
Aakash Desai , Daniel Walden , Thorvardur Ragnar Halfdanarson , Steven R Alberts , Robert R. McWilliams , Amit Mahipal , Daniel H. Ahn , Hani M. Babiker , Sri Harsha Tella , Patrick Walsh McGarrah , Sani Haider Kizilbash , Alex A. Adjei , Tanios S. Bekaii-Saab , Wen Wee Ma
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary
Track
Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary
Sub Track
Pancreatic Cancer
Citation
J Clin Oncol 40, 2022 (suppl 16; abstr 4130)
DOI
10.1200/JCO.2022.40.16_suppl.4130
Abstract #
4130
Poster Bd #
116
Abstract Disclosures
Similar Posters
Poster
2021 ASCO Annual Meeting
Clinical outcomes analysis of TP53-mutated advanced and metastatic biliary tract cancers.
First Author: Sunyoung S. Lee
Poster
2015 ASCO Annual Meeting
Discovery of new potentially actionable mutations in pancreatic ductal adenocarcinoma by next generation sequencing.
First Author: Mariacristina Di Marco
Poster
2024 ASCO Gastrointestinal Cancers Symposium
Clinical impact of KRAS mutations in metastatic pancreatic ductal adenocarcinoma (PDAC).
First Author: Carter Norton
Poster
2023 ASCO Gastrointestinal Cancers Symposium
Circulating tumor DNA–based genomic landscape of KRAS wild-type pancreatic adenocarcinoma.
First Author: Brendon Fusco